| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 12/05/2013 | WO2013144737A3 Novel 3,5-disubstitued-3h-imidazo[4,5-b]pyridine and 3,5- disubstitued -3h-[1,2,3]triazolo[4,5-b] pyridine compounds as modulators of c-met protein kinases |
| 12/05/2013 | WO2013142628A3 Antibiotic compounds and compositions, and methods for identification thereof |
| 12/05/2013 | WO2013140367A3 Composition for the treatment of pediculosis and corresponding manufacturing process |
| 12/05/2013 | WO2013136296A3 Water-soluble organometallic ruthenium and iron compunds presenting heteroaromatic ligands |
| 12/05/2013 | WO2013136192A3 Use of tetracycline compositions for wound treatment and skin restoration |
| 12/05/2013 | WO2013134534A3 Solid state forms of cabazitaxel and processes for preparation thereof |
| 12/05/2013 | WO2013132346A3 Compounds and uses thereof for treating inflammation and modulating immune responses |
| 12/05/2013 | WO2013115737A3 New pharmaceutical compositions of flurbiprofen and glucosamin |
| 12/05/2013 | WO2013109354A3 Etravirine formulations and uses thereof |
| 12/05/2013 | WO2013100882A3 Combinations of diacerein and non-steroidal inflammation drugs |
| 12/05/2013 | WO2013095318A3 Orally-disintegrating formulations of flurbiprofen |
| 12/05/2013 | WO2013092860A3 Hyaluronic acid and its use for treating venous insufficiency and varicose veins |
| 12/05/2013 | WO2012083122A8 Inhibitors of influenza viruses replication |
| 12/05/2013 | WO2012063134A3 Cardiac glycoside analogs in combination with emodin for cancer therapy |
| 12/05/2013 | WO2011061144A3 Use of beta-glucan for the increase of synthesis of collagen |
| 12/05/2013 | US20130324950 Transdermal delivery system containing galantamine or salts thereof |
| 12/05/2013 | US20130324759 Gamma-hydroxybutyrate compositions containing carbohydrate, lipid or amino acid carriers |
| 12/05/2013 | US20130324620 Spray Oil and Method of Use Thereof for Controlling Turfgrass Pests |
| 12/05/2013 | US20130324618 Method and composition for enhancing milk production |
| 12/05/2013 | US20130324614 Method for enhancing the bioavalability of ospemifene |
| 12/05/2013 | US20130324613 Use of polyunsaturated ketones for the treatment of psoriasis |
| 12/05/2013 | US20130324612 Aqueous gel formulation and method for inducing topical anesthesia |
| 12/05/2013 | US20130324611 Methods of using desensitizing drug products |
| 12/05/2013 | US20130324610 Cathepsin cysteine protease inhibitors |
| 12/05/2013 | US20130324609 Depression disorder therapeutics with creatine analogs |
| 12/05/2013 | US20130324608 Methods and compositions for treating, reducing or preventing damage to the nervous system of animals |
| 12/05/2013 | US20130324607 Methods of treating hypercholesterolemia |
| 12/05/2013 | US20130324605 Uses of cimiracemate a and related compounds for treating inflammation and modulating immune responses |
| 12/05/2013 | US20130324603 Pharmaceutical composition for treating inflammation and pain |
| 12/05/2013 | US20130324601 Pharmaceutical composition for treating inflammation and pain |
| 12/05/2013 | US20130324597 Pharmaceutical composition comprising trans-cinnamaldehyde and its use in the treatment of infections |
| 12/05/2013 | US20130324595 C-glucosidic ellagitannin compounds for use for altering the supramolecular arrangement of actin and for the treatment of osteoporosis, cancer, bacterial infection and viral infection |
| 12/05/2013 | US20130324594 Methods and compositions for preventing and treating auditory dysfunctions |
| 12/05/2013 | US20130324585 Rotigotine ionic liquid |
| 12/05/2013 | US20130324581 Pharmaceutical Composition Comprising (1r,4r)-6'-flouro-N,N-dimethyl-4-phenyl-4',9'-dihydro-3'H-spiro[cyclohexane-1,1'-pyrano-[3,4,b]indol]-4-amine and a propionic acid derivative |
| 12/05/2013 | US20130324580 Anti-Cancer Agents Synthesized Based On Miliusane Compounds |
| 12/05/2013 | US20130324578 Administration regime for nitrocatechols |
| 12/05/2013 | US20130324576 Therapeutic compounds |
| 12/05/2013 | US20130324575 Compositions and method for treatment of attention deficit disorder and attention deficit/hyperactivity disorder with methylphenidate |
| 12/05/2013 | US20130324574 Treatment of ocular inflammatory diseases using laquinimod |
| 12/05/2013 | US20130324572 Remedy for psychoneurotic diseases |
| 12/05/2013 | US20130324570 Inhibitors of late sv40 factor (lsf) as cancer chemotherapeutics |
| 12/05/2013 | US20130324568 Substituted indolyl alkyl amino derivatives as novel inhibitors of histone deacetylase |
| 12/05/2013 | US20130324565 Organic compounds |
| 12/05/2013 | US20130324563 Method of intensifying the physiological action of caffeine |
| 12/05/2013 | US20130324562 Fused bicyclic heterocycles useful as dipeptidyl peptidase-iv inhibitors |
| 12/05/2013 | US20130324559 Dendrimer like amino amides possessing sodium channel blocker activity for the treatment of dry eye and other mucosal diseases |
| 12/05/2013 | US20130324554 Amorphous form of vilazodone hydrochloride substantially free of crystalline forms |
| 12/05/2013 | US20130324552 Chemokine cxcr4 receptor modulators and used related thereto |
| 12/05/2013 | US20130324551 Thiazolylphenyl-benzenesulfonamido derivatives as kinase inhibitors |
| 12/05/2013 | US20130324548 Chemoembolization composition comprising anti-angiogenic agents |
| 12/05/2013 | US20130324545 Methods for the regulation of the prostaglandin f synthase (pgfs) activity of akr1b1 and uses thereof |
| 12/05/2013 | US20130324541 Potentiator of antitumor activity of chemotherapeutic agent |
| 12/05/2013 | US20130324539 Treatment of Multiple Sclerosis and Psoriasis Using Prodrugs of Methyl Hydrogen Fumarate |
| 12/05/2013 | US20130324535 Use of sigma ligands in bone cancer pain |
| 12/05/2013 | US20130324534 Combination of brimonidine and timolol for topical ophthalmic use |
| 12/05/2013 | US20130324526 [1,2,4] triazolo [4,3-b] pyridazine compounds as inhibitors of the c-met tyrosine kinase |
| 12/05/2013 | US20130324524 2,4-pyrimidinediamine compounds and their uses |
| 12/05/2013 | US20130324521 Implant for treating or preventing an aneurysm |
| 12/05/2013 | US20130324520 Rxrg modulators for the treatment of cancer |
| 12/05/2013 | US20130324519 Quinoxaline carboxamide derivatives as protein tyrosine kinase inhibitors |
| 12/05/2013 | US20130324517 Cyclic pyrimidin-4-carboxamides as ccr2 receptor antagonists for treatment of inflammation, asthma and copd |
| 12/05/2013 | US20130324514 Indanyloxyphenylcyclopropanecarboxylic acids |
| 12/05/2013 | US20130324513 Method for treating esophageal cancer |
| 12/05/2013 | US20130324509 Spinal cord injury, inflammation, and immune-disease: local controlled release of therapeutic agents |
| 12/05/2013 | US20130324507 Novel (aza)Benzhydryl Ether Derivatives, Their Process of Preparation and Their Use as H4-Receptor Ligands for Therapeutical Applications |
| 12/05/2013 | US20130324506 New 6,11-dihydro-5H-benzo[d]imidazo[1,2-a]azepines derivatives as histamine H4 receptor ligands |
| 12/05/2013 | US20130324505 Assays and methods of treatment relating to vitamin d insufficiency |
| 12/05/2013 | US20130324504 Antispasmodic 1,2-diols and 1,2,3-triols |
| 12/05/2013 | US20130324503 Method of identifying and treating a person having a predisposition to or afflicted with Parkinson disease |
| 12/05/2013 | US20130324502 Novel formulations for dermal, transdermal and mucosal use 1 |
| 12/05/2013 | US20130324501 Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors |
| 12/05/2013 | US20130324500 Spinal cord injury, inflammation and immune-disease: local controlled release of therapeutic agents |
| 12/05/2013 | US20130324497 Compositions and methods for treating hepatitis b virus infection |
| 12/05/2013 | US20130324496 Solid forms of an antiviral compound |
| 12/05/2013 | US20130324492 Maintenance of Platelet Inhibition During Antiplatelet Therapy |
| 12/05/2013 | US20130324491 Beta-l-2'-deoxy-nucleosides for the treatment of hepatitis b |
| 12/05/2013 | US20130324490 Biodegradable, water soluble and ph responsive poly(organo)phosphazenes |
| 12/05/2013 | US20130324487 Cyanidin-3-glucoside and Methods for Using the Same |
| 12/05/2013 | US20130324486 Method for producing cultured root of purple ginseng |
| 12/05/2013 | US20130324485 Method of Determining the Probability of a Therapeutic Response in Cancer Chemotherapy with Cardiac Glycoside |
| 12/05/2013 | US20130324484 Liver function-improving agent |
| 12/05/2013 | US20130324481 Sustained release eye drop formulations |
| 12/05/2013 | US20130324475 Arthroscopic Irrigation Solution and Method for Peripheral Vasoconstriction and Inhibition of Pain and Inflammation |
| 12/05/2013 | US20130324464 Aryl glycoside compound, preparation method and use thereof |
| 12/05/2013 | US20130324463 Use of a dpp-4 inhibitor for modifying food intake and regulating food preference |
| 12/05/2013 | US20130324461 Methods and compositions for preventing or treating obesity |
| 12/05/2013 | US20130324457 1-aryl-5-alkyl pyrazole derivative compounds, processes of making and methods of using thereof |
| 12/05/2013 | US20130323755 Diagnostic tumor markers, drug screening for tumorigenesis inhibition, and compositions and methods for treatment of cancer |
| 12/05/2013 | US20130323330 Methods for inhibiting prostate cancer by kinases and angiogenesis inhibitory mechanisms of ball moss extract |
| 12/05/2013 | US20130323329 Method Of Using Rhein For Treating Fibrotic Conditions And Tumors |
| 12/05/2013 | US20130323319 Modified immune-modulating particles |
| 12/05/2013 | US20130323318 Protein free surfactant composition for pulmonary diseases and a process for preparing the same |
| 12/05/2013 | US20130323317 Injectable and swellable microspheres for tissue bulking |
| 12/05/2013 | US20130323316 Injectable microspheres for dermal augmentation and tissue bulking |
| 12/05/2013 | US20130323315 Microspheres Including Oxidized Cellulose |
| 12/05/2013 | US20130323309 Sustained Release Composition of Memantine |
| 12/05/2013 | US20130323307 Sildenafil-free base-containing film preparation and method for producing same |
| 12/05/2013 | US20130323304 Methods For Enhancing The Release And Absorption of Water Insoluble Active Agents |
| 12/05/2013 | US20130323303 Drug carrier and preparation method thereof |